Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 3
1997 2
1998 3
1999 4
2000 1
2001 1
2002 2
2003 1
2004 2
2005 1
2008 1
2009 2
2010 6
2011 6
2012 9
2013 4
2014 6
2015 4
2016 9
2017 7
2018 11
2019 7
2020 2
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
[Feber efter rejse til Iran].
Goldschmidt MI, Andrews V, Pedersen M, Schønning K. Goldschmidt MI, et al. Among authors: schonning k. Ugeskr Laeger. 2020 Jun 1;182(23):V71004. Ugeskr Laeger. 2020. PMID: 32515343 Danish. No abstract available.
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants.
Jensen SB, Fahnøe U, Pham LV, Serre SBN, Tang Q, Ghanem L, Pedersen MS, Ramirez S, Humes D, Pihl AF, Filskov J, Sølund CS, Dietz J, Fourati S, Pawlotsky JM, Sarrazin C, Weis N, Schønning K, Krarup H, Bukh J, Gottwein JM. Jensen SB, et al. Among authors: schonning k. Hepatology. 2019 Sep;70(3):771-787. doi: 10.1002/hep.30647. Epub 2019 Jun 5. Hepatology. 2019. PMID: 30964552 Free PMC article. Review.
Surveillance of vancomycin-resistant enterococci reveals shift in dominating clones and national spread of a vancomycin-variable vanA Enterococcus faecium ST1421-CT1134 clone, Denmark, 2015 to March 2019.
Hammerum AM, Justesen US, Pinholt M, Roer L, Kaya H, Worning P, Nygaard S, Kemp M, Clausen ME, Nielsen KL, Samulioniené J, Kjærsgaard M, Østergaard C, Coia J, Søndergaard TS, Gaini S, Schønning K, Westh H, Hasman H, Holzknecht BJ. Hammerum AM, et al. Among authors: schonning k. Euro Surveill. 2019 Aug;24(34):1900503. doi: 10.2807/1560-7917.ES.2019.24.34.1900503. Euro Surveill. 2019. PMID: 31456560 Free PMC article.
Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome.
Fahnøe U, Pedersen MS, Sølund C, Ernst A, Krarup HB, Røge BT, Christensen PB, Laursen AL, Gerstoft J, Thielsen P, Madsen LG, Pedersen AG, Schønning K, Weis N, Bukh J. Fahnøe U, et al. Among authors: schonning k. J Viral Hepat. 2021 Feb;28(2):302-316. doi: 10.1111/jvh.13430. Epub 2020 Nov 25. J Viral Hepat. 2021. PMID: 33131178
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page